跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Suritricef-1000 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Suritricef-1000
Approved
STANDARD
Suritricef-1000
Yeluri Formulations Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f4aaae0a9f34ea7b
Company
Yeluri Formulations Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
f4aaae0a9f34ea7b
Drug Approval Philippines Name
Suritricef-1000
Product Name
Suritricef-1000
Registration Number
DRP-11294
Brand Name
Suritricef-1000
Generic Name
Ceftriaxone (as Sodium)
Dosage Form
Powder for Injection (IM/IV)
Dosage Strength
1 g
Manufacturer
Yeluri Formulations Pvt. Ltd.
Importer
Pharma-Surrey International Inc.
Distributor
Pharma-Surrey International Inc.
Issuance Date
28 February 2022
Expiry Date
22 November 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f4aaae0a9f34ea7b
Type
Standard
Back to Philippines FDA Approvals